Reporting owner · CIK 0001823563

Chambers Rebecca

Visual SEC Form 4 history across 2 companies, 8 transactions and 4 filings.

CFOChief Financial OfficerVERACYTE, INC.
Open-market mix
Filings4Form 4 records
Buying$00 purchases
Selling$180.5K3 sales
Net value−$180.5KBuys minus sells
Companies21 securities
Most recentSep 04, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-51Feb 25Mar 252Sep 26

Net value flow

Buys minus sells

Feb 25
−$23.1K
Mar 25
$0
Sep 26
−$157.4K

Transaction texture

Ownership and ticket size

Average P/S size$60.2K
Median P/S size$51.4K
Direct8
Indirect0
Sep 04, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at VERACYTE, INC. on Sep 04, 2026 valued at $51,364.

Review SEC filing
Latest buy

No open-market insider purchase is available.

TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
VCYTChambers Rebecca
CFO
sale10b5-11.17k-$5.13MS0.0%09/0409/04
VCYTChambers Rebecca
CFO
sale10b5-12.47k-$10.6MS0.0%09/0409/04
VCYTChambers Rebecca
CFO
withholding10b5-13.60k-$16.1MF0.0%09/0409/02
VCYTChambers Rebecca
CFO
withholding11.0k-$38.4MF03/03/202503/02/2025
VCYTChambers Rebecca
CFO
withholding11.9k-$40.3MF03/03/202502/27/2025
VCYTChambers Rebecca
CFO
grant23.1k$0A03/03/202502/27/2025
NARIChambers Rebecca
DIR
U9.68kU02/20/202502/19/2025
VCYTChambers Rebecca
CFO
sale10b5-1527-$2.31MS02/05/202502/03/2025

Chambers Rebecca Insider Activity FAQ

SEC Form 4 context

Who is Chambers Rebecca?

Chambers Rebecca is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001823563.

Which companies has Chambers Rebecca reported transactions for?

VERACYTE, INC., Inari Medical, Inc.

When was Chambers Rebecca's latest insider buy?

No open-market insider purchase is available for this period.

When was Chambers Rebecca's latest insider sale?

sale at VERACYTE, INC. on Sep 04, 2026 valued at $51,364.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.